GLOBUS MEDICAL INC
For the period ended Mar 31, 2025. Filed May 8, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2025 · Filed May 8, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 5. Other Information
Other Information
During the three months ended March 31, 2025, one of the Company's directors and officers adopted, modified or terminated a “Rule 10b5-1 trading arrangement” or a “non-Rule 10b5-1 trading arrangement” as each term is defined under Item 408 of Regulation S-K.
On March 15, 2025, Keith Pfeil, the Company’s Executive Vice President, Chief Operating Officer and Chief Financial Officer, modified a trading arrangement for the sale of securities of the Company’s Class A Common that is intended to satisfy the affirmative defense conditions of Securities Exchange Act Rule 10b5-1(c) (a “Rule 10b5-1 Trading Plan”). Mr. Pfeil’s Rule 10b5-1 Trading Plan, which had a term ending upon the earlier of March 15 ,2025, or the sale of all shares subject to the plan was extended, to terminate upon the earlier of March 15, 2026, or the sale of all shares subject to the plan, and provides for the sale of up to 165,625 shares of Class A Common pursuant to the terms of the plan.
Item 6.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.